The Bleeding Risk in Antithrombotic Therapies: A Narrative Review.

Details

Serval ID
serval:BIB_6B648DA7FA0E
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
The Bleeding Risk in Antithrombotic Therapies: A Narrative Review.
Journal
Current vascular pharmacology
Author(s)
Alatri A., Mazzolai L.
ISSN
1875-6212 (Electronic)
ISSN-L
1570-1611
Publication state
Published
Issued date
2020
Peer-reviewed
Oui
Volume
18
Number
3
Pages
237-248
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
Bleeding represents the most important complication of antithrombotic treatment, including anticoagulant and antiplatelet therapies. A number of scores were proposed to evaluate the risk of bleeding both for anticoagulant and antiplatelet treatment. In the last decade, 5 bleeding risk scores were published for use in atrial fibrillation patients, and 3 scores for patients receiving anticoagulants for venous thromboembolism therapy or prophylaxis. In addition, 3 scores were recently developed to assess inhospital or short-term bleeding risk in patients receiving antiplatelet therapy after Acute Coronary Syndrome (ACS) and Percutaneous Coronary Intervention (PCI). Furthermore, 3 additional scores have focused on long-term bleeding in outpatients receiving dual antiplatelet therapy after PCI. The aim of this review is to consider the evidence on bleeding scores.
Keywords
Bleeding, Clinical predictive rules, acute coronary syndrome, anticoagulants, antiplatelet therapy., atrial fibrillation, percutaneous coronary intervention, venous thromboembolism, antiplatelet therapy, clinical predictive rules, percutaneous coronary intervention, venous thromboembolism.
Pubmed
Web of science
Create date
14/02/2019 16:27
Last modification date
13/06/2020 6:20
Usage data